Tirofiban is mainly used to treat acute coronary syndrome and prevent thrombosis after coronary arterial intervention.
Tirofiban is an anti-platelet aggregation drug,whichmainly inhibitsplatelet aggregationby inhibiting the synthesis of platelets, so as to prevent thrombosis. Tirofiban has obvious effect on physiological platelet aggregation caused by various causes and iscommonlyused in acute coronary syndrome.The dosage of tirofibanis proportional to its antiplatelet aggregation effect. Therefore, continuous intravenous drip can effectively prevent thrombosis, or reduce existing thrombosis, and can accelerate the process of arterial reperfusion, and can also be used to preventthe occurrence ofcomplications such as myocardial ischemia.
The drug should be used under the guidance of a doctor. During the use, attention should be paid to whether there is abnormal bleeding tendency to prevent serious bleeding problems.
Contraindication
1.It is forbidden for those allergic to tirofiban.
2.It is forbidden forpatients witha history ofactive bleeding, thrombocytopeniaor bleeding.
3.It is forbidden forpatients witha history ofintracranial hemorrhage, intracranial tumor, arteriovenous malformation, aneurysmor acute pericarditis.
4.It is forbidden forpatientswho have a history of stroke, any hemorrhagic moderate wind, who have undergone major organ surgery or who have severe trauma and need surgical treatment within 1 month before using tirofiban.
5.It is forbidden forpatients with a history of fractionated branch aneurysm, severe hypertensionor taking other intravenous GP Ⅱb/Ⅲa receptor antagonists.
+862985691802
[email protected]
No.5 Chuangxin Road,New Industry Park,Gaoxin District,Xi'an,China/710119
